Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib

Vamsi K. Kota, Jee Hyun Kong, Martha Arellano, Fuad El Rassi, Manila Gaddh, Leonard T. Heffner, Elliott F. Winton, Anand P. Jillella, Morgan L. McLemore, H. Jean Khoury

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences